Showing results (2201-2210 of 2,503) with videos related to

Sort By:
Pageof 251
Annals of the Rheumatic Diseases|August 9, 2011
Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomesJ Bathon, M Robles, A C Ximenes, et al.
Journal of the American College of Cardiology|March 19, 2013
Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trialJonathan P Piccini, Susanna R Stevens, Yuliya Lokhnygina, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
A genome-wide meta-analysis identifies a sex-specific genetic effect for platelet aggregation in response to agonistsJulius S Ngwa, Ming-Huei Chen, Gaynor Brady, et al.
Stroke|April 26, 2014
Rivaroxaban for stroke prevention in East Asian patients from the ROCKET AF trialKa Sing Lawrence Wong, Dai Yi Hu, Abraham Oomman, et al.
Hypertension (Dallas, Tex. : 1979)|July 23, 2019
Association of Blood Pressure Level With Left Ventricular Mass in AdolescentsElaine M Urbina, Brenda Mendizábal, Richard C Becker, et al.
European Heart Journal|May 4, 2015
Effect of genetic variations on ticagrelor plasma levels and clinical outcomesChristoph Varenhorst, Niclas Eriksson, Åsa Johansson, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2014
Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI studyThomas J Povsic, John P Vavalle, John H Alexander, et al.
Heart Rhythm O2|August 2, 2021
Pharmacotherapy for diabetes and stroke risk: Results from ROCKET AFFrancis E Ugowe, Anne S Hellkamp, Allen Wang, et al.
American Heart Journal|June 15, 2018
Impact of polyvascular disease on patients with atrial fibrillation: Insights from ROCKET AFSean T Chen, Anne S Hellkamp, Richard C Becker, et al.
Journal of the American Heart Association|June 16, 2017
Safety and Efficacy of Rivaroxaban in Patients With Cardiac Implantable Electronic Devices: Observations From the ROCKET AF TrialGeorge C Leef, Anne S Hellkamp, Manesh R Patel, et al.
Pageof 251